Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Prospective, randomized, double-blinded, placebo-controlled clinical investigation of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo
This clinical investigation is a prospective, randomized, double-blinded, placebo-controlled study of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo.
Inclusion Criteria:
Exclusion Criteria:
Prague, Central Bohemia 140 24, Czechia